List of bibliographic references
Number of relevant bibliographic references: 12.
| Ident. | Authors (with country if any) | Title |
|---|
| 000531 (2015) |
Javier Castro-Hernández [Espagne] ; Domingo Afonso-Oramas [Espagne] ; Ignacio Cruz-Muros [Espagne] ; Josmar Salas-Hernández [Espagne] ; Pedro Barroso-Chinea [Espagne] ; Rosario Moratalla [Espagne] ; Mark J. Millan [France] ; Tomás González-Hernández [Espagne] | Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake. |
| 000B77 (2013-03-31) |
Sylvia Navailles [France] ; Mélanie Lagière [France] ; Audrey Roumegous ; Marina Polito ; Méric B. Boujema ; Martine Cador [France] ; John Dunlop ; Marie-Françoise Chesselet ; Mark J. Millan ; Philippe De Deurwaerdère [France] | Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease. |
| 000C60 (2013) |
Sylvia Navailles [France] ; Mélanie Lagière ; Audrey Roumegous ; Marina Polito ; Méric B. Boujema ; Martine Cador ; John Dunlop ; Marie-Françoise Chesselet ; Mark J. Millan ; Philippe De Deurwaerdère | Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease. |
| 001174 (2012) |
Chantevy Pou ; Clotilde Mannoury La Cour ; Leigh A. Stoddart ; Mark J. Millan ; Graeme Milligan | Functional Homomers and Heteromers of Dopamine D2L and D3 Receptors Co-exist at the Cell Surface |
| 001285 (2012) |
Martin Egeland [Suède] ; Xiaoqun Zhang [Suède] ; Mark J. Millan [France] ; Elisabeth Mocaer [France] ; Per Svenningsson [Suède] | Pharmacological or genetic blockade of the dopamine D3 receptor increases cell proliferation in the hippocampus of adult mice |
| 001B42 (2010) |
Mark J. Millan [France] | From the cell to the clinic: a comparative review of the partial D₂/D₃receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease. |
| 002C51 (2006) |
Mauricette Brocco [France] ; Anne Dekeyne ; Mariusz Papp ; Mark J. Millan | Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors. |
| 002E73 (2006) |
Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France] | Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets : Mediation by D2, not D3, dopamine receptors |
| 002E75 (2006) |
Naomi P. Visanji [Canada] ; Mark J. Millan [France] ; Jonathan M. Brotchie [Canada] | Actions at sites other than D3 receptors mediate the effects of BP897 on L-DOPA-induced hyperactivity in monoamine-depleted rats |
| 003712 (2003) |
Roberto Maggio [Italie] ; Marco Scarselli [Italie] ; Francesca Novi [Italie] ; Mark J. Millan [France] ; Giovanni U. Corsini [Italie] | Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole |
| 003720 (2003) |
Jeffrey N. Joyce [États-Unis] ; Steve Presgraves [États-Unis] ; Lynn Renish [États-Unis] ; Sabinne Borwege [États-Unis] ; Tracy Osredkar [États-Unis] ; Diane Hagner [États-Unis] ; Maria Replogle [États-Unis] ; Mateo Pazsoldan [États-Unis] ; Mark J. Millan [France] | Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole |
| 003E37 (2001) |
Adrian Newman-Tancredi [France] ; Didier Cussac [France] ; Mauricette Brocco [France] ; Jean-Michel Rivet [France] ; Christine Chaput [France] ; Manuelle Touzard [France] ; Valérie Pasteau [France] ; Mark J. Millan [France] | Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "Mark J. Millan"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i \
-Sk "Mark J. Millan" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Main
|étape= Merge
|type= indexItem
|index= Author.i
|clé= Mark J. Millan
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 |  |
